SCHEMBL7355241

SCHEMBL7355241

COc1ccc(S(=O)(=O)OC(=O)C2CCN(Cc3cccc(OC)c3)CC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.67
ALDH1A1 P00352 2/20 0.67
MAPT P10636 1/20 0.67
POLB P06746 1/20 0.56
MMP1 P03956 1/20 0.56
MMP9 P14780 1/20 0.56
MMP13 P45452 1/20 0.56
ADAM17 P78536 1/20 0.56
PKM P14618 1/20 0.54
CCR8 P51685 1/20 0.53
LMNA P02545 2/20 0.52
HTT P42858 1/20 0.52
SIGMAR1 Q99720 2/20 0.51
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
DRD4 P21917 1/20 0.49
ACHE P22303 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
CACNA1G O43497 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567555 0.89 MEN1 (0.54) KDM4EALDH1A1MAPTPOLBMMP1
SCHEMBL7956096 0.85 MMP1 (0.55) KDM4EALDH1A1MAPTPOLBMMP1
SCHEMBL7998480 0.82 OPRM1 (0.55) MMP1MMP9MMP13ADAM17PKM
SCHEMBL7509075 0.82 MMP1 (0.61) KDM4EALDH1A1MAPTMMP1MMP9
SCHEMBL7345881 0.82 S1PR5 (0.60) ALDH1A1MAPTMMP1MMP9MMP13
SCHEMBL7506962 0.78 MMP1 (0.54) ALDH1A1POLBMMP1MMP9MMP13
SCHEMBL28801570 0.75 SIGMAR1 (0.70) KDM4EALDH1A1MAPTPOLBSIGMAR1
SCHEMBL17099412 0.75 CCR8 (0.62) KDM4EALDH1A1MAPTPOLBCCR8
SCHEMBL17099350 0.74 KDM4E (0.62) KDM4EALDH1A1MAPTPOLBCCR8
SCHEMBL6565426 0.74 MMP1 (0.80) MMP1MMP9MMP13ADAM17SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331563-B1 LOW MOLECULAR WEIGHT, NON-PEPTIDE INHIBITORS OF MATRIX METALLOPROTEINASES AND TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME; TREATING ARTHRITIS, TUMOR METASTASIS, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, INSULIN RESISTANCE WYETH HOLDINGS CORPORATION 2001-12-18 US disclosed
US-6197791-B1 ANTIARTHRITIC AGENTS; WOUND HEALING AGENTS; ANTITUMOR AGENTS AMERICAN CYANAMID COMPANY 2001-03-06 US disclosed
EP-1054858-A1 N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED-ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS American Cyanamid Company (US) 2000-11-29 EP disclosed
EP-0973512-A1 N-HYDROXY-2-(ALKYL, ARYL OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS American Cyanamid Company (US) 2000-01-26 EP disclosed
EP-0970046-A1 N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS American Cyanamid Company (US) 2000-01-12 EP disclosed
WO-1999042436-A1 N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED-ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1999-08-26 WO disclosed
WO-1998038163-A1 N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1998-09-03 WO disclosed
WO-1998037877-A1 N-HYDROXY-2-(ALKYL, ARYL OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1998-09-03 WO disclosed